Author

S. M. Rainey

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:clinical cohort / trial· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

A. Kohl· 1 shared A. M. Szemiel· 1 shared A. Taggart· 1 shared C. Davis· 1 shared D. Kovacs· 1 shared E. C. Thomson· 1 shared F. Marra· 1 shared J. T. Scott· 1 shared

Activity by Year

2021-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

A. Kohl

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

MicrobiologybioRxivPreprintMar 25, 2021

COVID-19: A need for new rather than repurposed antiviral drugs.

D. Kovacs, C. Davis, P. Cannon…·J. T. Scott

This paper reviews 29 FDA-approved antiviral compounds for COVID-19 treatment, finds limited clinical efficacy of repurposed drugs, and highlights the need for novel antivirals.

DOI 10.1101/2021.03.25.436935

humanclinical cohort / trial

𝕏 PostBluesky